Shareholders' equity · 2012–2025

Novocure shareholders' equity

$340M−5.5% · FY2025

Novocure (NVCR) reported $340M in shareholders' equity for fiscal 2025, −5.5% year on year.

$49.4M2012$172M2013$97.9M2014$251M2015$142M2016$114M2017$112M2018$218M2019$477M2020$410M2021$441M2022$362M2023$360M2024$340M2025
Novocure — Shareholders' equity, 2012–2025
Fiscal yearShareholders' equityChangeFiling
FY20252025-12-31$340M−5.5%Open →
FY20242024-12-31$360M−0.6%Open →
FY20232023-12-31$362M−17.8%Open →
FY20222022-12-31$441M+7.5%Open →
FY20212021-12-31$410M−13.9%Open →
FY20202020-12-31$477M+118.8%Open →
FY20192019-12-31$218M+94.0%Open →
FY20182018-12-31$112M−1.1%Open →
FY20172017-12-31$114M−20.2%Open →
FY20162016-12-31$142M−43.2%Open →
FY20152015-12-31$251M+156.3%Open →
FY20142014-12-31$97.9M−43.0%Open →
FY20132013-12-31$172M+247.6%Open →
FY20122012-12-31$49.4M—Open →

Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2012–2025 compound annual growth +16.0%

Shareholders' equity at companies of similar size

Full ranking by shareholders' equity →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Novocure shareholders' equity |url=https://companiesranked.com/en/company/novocure/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Novocure shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/novocure/shareholders-equity

BibTeX

@misc{companiesranked-en-company-novocure-shareholders-equity-2026,
  author       = {{CompaniesRanked}},
  title        = {{Novocure shareholders' equity}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/novocure/shareholders-equity}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001645113-26-000062 · July 23, 2026

{{cite web |title=Novocure shareholders' equity — 10-Q (0001645113-26-000062) |url=https://www.sec.gov/Archives/edgar/data/1645113/000164511326000062/nvcr-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-23}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Novocure overview